Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
Olaf Heidenreich benoemd tot hoogleraar Experimentele pediatrische hemato-oncologie
dec 2024 | Leukemie